[Prolonged traumatic and vascular coma: prognostic and therapeutic indications based on hemodynamic and metabolic studies].
From haemodynamic and metabolic investigation of 65 comatose subjects following cranial traumatism or cerebral vascular accident, the following prognostic and therapeutic indications emerged: The isolated increase in oxygen pressure in the jugular vein to above 50 mm Hg, the simultaneous decrease in circulation of the brain to below of 30 ml/100g/min., and of the brain consumption of oxygen to below 1.5 ml/100g/min., combined with a loss of autoregulation and a decrease in carbon dioxide reactivity indicate that prognosis is very poor. Induced arterial hypertension, associated with hyperventilation, partially corrects brain hypoperfusion in coma from bulbo-pontine lesions. Sodium penthiobarbital and sodium gamma hydroxybutyrate and have the effect of reducing oxygen metabolism which might have some therapeutic value during the acute phase of coma. Clomipramine which has a stimulating effect on oxygen metabolism should be kept in reserve for the chronic phase of prolonged coma.
D001784:Blood Gas Analysis; D001921:Brain / Q000378:metabolism; D002245:Carbon Dioxide / Q000032:analysis; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000150:complications*; D002997:Clomipramine / Q000627:therapeutic use; D003128:Coma / Q000175:diagnosis*; D006259:Craniocerebral Trauma / Q000150:complications*; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use; D007511:Ischemia / Q000628:therapy; D008680:Metaraminol; D010101:Oxygen Consumption; D010424:Pentobarbital / Q000627:therapeutic use; D011379:Prognosis; D012121:Respiration, Artificial
D006885:Hydroxybutyrates; D002245:Carbon Dioxide; D008680:Metaraminol; D010424:Pentobarbital; D002997:Clomipramine
Comas traumatiques et vasculaires prolongés: indications pronostiques et thérapeutiques d'après une étude hémodynamique et métabolique